Clinical Trials Browser

Phase 2 × Refractory Solid Tumors × Arsenic Trioxide × Clear all

NCT04869475 2021-05-13

Arsenic Trioxide in Refractory Solid Tumors With Rescuable p53 Mutation

Phase 2 Unknown

Other solid neoplasm

Refractory Solid Tumors